Nuvation Bio Inc. (NUVB) Misses Q2 EPS by 183c
Tweet
Share
E-mailGet Alerts NUVB Hot Sheet
Join SI Premium – FREE
Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($1.89), $1.83 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.44 million.
For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- QSE closes $6M private placement with final tranche of $674K
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
